A medicine that reaches the pharmacy today often traces back to lab work done decades earlier. The money that pays for research moves on a much shorter clock. It arrives in grant cycles that expire long before the science does, and Jean-Pierre Conte has built part of his giving around closing that gap.Conte, the founder and managing partner of the ...
